Full Text View
Tabular View
No Study Results Posted
Related Studies
A Safety Study Of A Single Vaginal Administration Of P2G12 Antibody In Healthy Female Subjects
This study has been completed.
Study NCT01403792   Information provided by University of Surrey

First Received on July 26, 2011.   Last Updated on December 21, 2011   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Human Immunodeficiency Virus
Additional conditions recognized in this trial
Acquired Immunodeficiency Syndrome
HIV Infections
Immunologic Deficiency Syndromes
More general conditions related to this trial
Immune System Diseases
Lentivirus Infections
Retroviridae Infections
RNA Virus Infections
Sexually Transmitted Diseases
Sexually Transmitted Diseases, Viral
Slow Virus Diseases
Virus Diseases
Interventions listed in this trial
P2G12
Additional drug interventions recognized in this trial
Antibodies
More general drug interventions related to this trial
Immunologic Factors
Pharmacologic Actions
Physiological Effects of Drugs
Sponsors listed in this trial
University of Surrey
European Commission


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services